S 12363: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 154572898 |
| MeSH ID | M0176476 |
| Synonym |
|---|
| s-12363 |
| vinfosiltine sulfate |
| s 12363 |
| unii-jt6020n64h |
| vincaleukoblastine, o4-deacetyl-3-de(methoxycarbonyl)-3-(((1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)-, (3(s))-, sulfate (1:1) (salt) |
| jt6020n64h , |
| 142102-11-2 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (92.31) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 4 (22.22%) | 5.53% |
| Reviews | 1 (5.56%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (72.22%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Human pharmacokinetics of a new Vinca alkaloid S 12363 with use of a monoclonal antibody-based radio- or enzyme immunoassay. Cancer research, Aug-01, Volume: 53, Issue: 15 | 1993 |
| Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivative. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 22, Issue: 7 | 1992 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Human pharmacokinetics of a new Vinca alkaloid S 12363 with use of a monoclonal antibody-based radio- or enzyme immunoassay. Cancer research, Aug-01, Volume: 53, Issue: 15 | 1993 |
| Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (vinfosiltine). European journal of cancer (Oxford, England : 1990), Volume: 29A, Issue: 13 | 1993 |
| Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363. Cancer research, May-01, Volume: 51, Issue: 9 | 1991 |
| Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivative. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 22, Issue: 7 | 1992 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |